Fink Jeffrey Arvin 4
4 · Lipocine Inc. · Filed Jun 10, 2022
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Fink Jeffrey Arvin
Director
Transactions
- Award
Common Stock (Right to Buy)
2022-06-08$0.92/sh+22,000$20,240→ 136,000 totalExercise: $0.92From: 2023-06-08Exp: 2032-06-08→ Common Stock (22,000 underlying)